Treatment of localized renal cell carcinoma

被引:0
|
作者
Brinkmann, Isabel [1 ]
Stief, Christian G. [1 ]
Marcon, Julian [1 ]
机构
[1] LMU Klinikum, Urol Klin & Poliklin, Marchioninistr 15, D-81377 Munich, Germany
来源
UROLOGIE | 2024年
关键词
Renal cell carcinoma; Nephrectomy; Ablative therapy; Neoplasia of the kidney; Therapy strategy; INVASIVE PARTIAL NEPHRECTOMY; RADICAL NEPHRECTOMY; SURGICAL-MANAGEMENT; TUMORS; CRYOABLATION; SURVEILLANCE; RADIOTHERAPY; PROGRESSION; PREDICTORS; ABLATION;
D O I
10.1007/s00120-023-02272-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Both partial nephrectomy (pNx) and total nephrectomy (TNx) are the mainstay of the surgical treatment of renal cell carcinoma. In smaller masses, ablative treatment as well as surveillance are possible options. Objective: The aim of this article is to provide a closer look at the surgical methods, active surveillance and ablative options as well as the current evidence to support their use. Material and methods: This study is based on a selective literature review regarding pNx and TNx for renal cell carcinoma using the PubMed database and the review of current European and American guidelines on surgical treatment and conservative options for renal cell carcinoma. Results: The choice of surgical method depends on the intrarenal tumor configuration as well as patient comorbidities. While pNx is used for smaller localized masses TNx is usually performed in larger more complex tumors. Both methods can be performed using a minimally invasive (laparoscopic or robotically assisted) or an open approach. In patients with severe comorbidities or a limited life expectancy, local ablative treatment options as well as surveillance strategies are suitable strategies.
引用
收藏
页码:176 / 183
页数:8
相关论文
共 50 条
  • [41] Therapie des lokalisierten NierenzellkarzinomsTreatment of localized renal cell carcinoma
    Isabel Brinkmann
    Christian G. Stief
    Julian Marcon
    Die Urologie, 2024, 63 (2) : 176 - 183
  • [42] Therapie des lokalisierten NierenzellkarzinomsTreatment of localized renal cell carcinoma
    Isabel Brinkmann
    Christian G. Stief
    Julian Marcon
    Die Nephrologie, 2024, 19 (4) : 252 - 259
  • [43] Reasonability of lymph dissection in localized types of renal cell carcinoma
    Rahimov, N.
    Tillyashaykhov, M.
    Norovich, O.
    Kolesnikova, E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 : S21 - S21
  • [44] Renal cell carcinoma treatment - introduction
    Siedlecki, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2007, 3 : A1 - A2
  • [45] Adjuvant Treatment in Renal Cell Carcinoma
    Dizman, Nazli
    Adashek, Jacob J.
    Hsu, JoAnn
    Bergerot, Paulo G.
    Bergerot, Cristiane D.
    Pal, Sumanta K.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (08) : 555 - 563
  • [46] Adjuvant treatment for renal cell carcinoma
    Lam, JS
    Belldegrun, AS
    Figlin, RA
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (06) : 705 - 720
  • [47] Lenvatinib for the treatment of renal cell carcinoma
    Roviello, Giandomenico
    Corona, Silvia Paola
    Bozza, Giovanni
    Aieta, Michele
    Generali, Daniele
    Rodriquenz, Maria Grazia
    Mileo, Anna Maria
    Imperatori, Marco
    Ianza, Anna
    Conca, Raffaele
    Sobhani, Navid
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (05) : 507 - 512
  • [48] Systemic treatment of renal cell carcinoma
    Ivanyi, P.
    Gruenwald, V.
    ONKOLOGE, 2019, 25 (06): : 517 - 522
  • [49] Local treatment of renal cell carcinoma
    Distler, Florian
    Pahernik, Sascha
    ONKOLOGE, 2019, 25 (06): : 512 - 516
  • [50] Treatment of metastatic renal cell carcinoma
    Maxine Sun
    Giovanni Lughezzani
    Paul Perrotte
    Pierre I. Karakiewicz
    Nature Reviews Urology, 2010, 7 : 327 - 338